Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Kelsen

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapyJ P O'Connell, M G Kris, R J Gralla, et al.
Cancer|February 1, 1985
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsM G Kris, R J Gralla, L B Tyson, et al.
Diseases of the Colon and Rectum|May 1, 1997
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerA Grann, B D Minsky, A M Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicinG K Schwartz, D Ward, L Saltz, et al.
Cancer|March 15, 1983
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerL M Itri, R J Gralla, D P Kelsen, et al.
Cancer Treatment Reports|September 1, 1986
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancerM G Kris, R J Gralla, M S Wertheim, et al.
International Journal of Cancer|February 20, 1995
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agentsY Nabeya, F Loganzo, P Maslak, et al.
The New England Journal of Medicine|October 15, 1981
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomitingR J Gralla, L M Itri, S E Pisko, et al.
Cancer Research|November 1, 1982
Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II)D P Kelsen, H Scher, N Alcock, et al.
Cancer|January 10, 2001
A phase II study of irinotecan in patients with advanced hepatocellular carcinomaE M O'Reilly, K E Stuart, P M Sanz-Altamira, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapyJ P O'Connell, M G Kris, R J Gralla, et al.
Cancer|February 1, 1985
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsM G Kris, R J Gralla, L B Tyson, et al.
Diseases of the Colon and Rectum|May 1, 1997
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerA Grann, B D Minsky, A M Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicinG K Schwartz, D Ward, L Saltz, et al.
Cancer|March 15, 1983
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerL M Itri, R J Gralla, D P Kelsen, et al.
Cancer Treatment Reports|September 1, 1986
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancerM G Kris, R J Gralla, M S Wertheim, et al.
International Journal of Cancer|February 20, 1995
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agentsY Nabeya, F Loganzo, P Maslak, et al.
The New England Journal of Medicine|October 15, 1981
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomitingR J Gralla, L M Itri, S E Pisko, et al.
Cancer Research|November 1, 1982
Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II)D P Kelsen, H Scher, N Alcock, et al.
Cancer|January 10, 2001
A phase II study of irinotecan in patients with advanced hepatocellular carcinomaE M O'Reilly, K E Stuart, P M Sanz-Altamira, et al.
Pageof 13